title: Autologous bone marrow transplantation in patients with AML in second complete remission (CR).
authors.affiliation: University La Sapienza, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: P
authors.initials: P
authors.lastname: De Fabritiis
authors.forename: S
authors.initials: S
authors.lastname: Amadori
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
authors.forename: A
authors.initials: A
authors.lastname: Pulsoni
authors.forename: A
authors.initials: A
authors.lastname: Sandrelli
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000293:Adolescent; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002330:Carmustine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery*; D008297:Male; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D002330:Carmustine